All rifaximin articles
-
News‘Low risk’ antibiotic has led to an almost untreatable superbug
A new study has found that an antibiotic for liver disease patients could expose them to greater risk of a dangerous superbug.
-
NewsNovel combination therapy counters antibiotic-resistant Mycobacterium infections
Researchers have discovered a novel therapy by combining two antibiotics, rifaximin and clarithromycin, to treat Mycobacterium abscessus, a non-tuberculous mycobacterium (NTM) that causes chronic lung-related infections.
